Portfolio comparison
University of Pennsylvania vs Immatics Biotechnologies
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
University of Pennsylvania
Patents indexed
2
Year range
2022
Most recent
2022
biotechpharmaceuticalgene_editing
Top Patents2 enriched
US 11499167· 2022
Engineering Cells to Make Gene Therapy Viruses Using AAVrh.10
US 11357868· 2022
New Adeno-Associated Virus Capsids for Gene Therapy
Activity by Decade
2020s2
Company B
Immatics Biotechnologies
Patents indexed
9
Year range
2019 – 2024
Most recent
2024
biotechpharmaceuticalimmunotherapyoncologygene_editing
Top Patents9 enriched
US 11407807· 2022
Using Specific Immune Cells to Fight Cancers Like Lung and Breast Cancer
US 10377797· 2019
Training Immune Cells to Fight Cancer Using Specific Markers
US 12006349· 2024
How a Specific Peptide Can Train Your Immune System to Fight Cancer
Activity by Decade
2010s3
2020s6
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.